Search
for
Sort by
Research 901–930 of 1000+
- Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications
- Chitosan Nanoparticles for Topical Drug Delivery in Chemotherapy-Induced Alopecia: A Comparative Study of Five Repurposed Pharmacological Agents
- Bad Hair Days: A Clinical and Trichoscopic Evaluation of Scalp Lesions
- COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists
- Efficacy and Safety of Tofacitinib in Paediatric Alopecia Aerata - A Prospective Observational Study
- Unique Circulating MicroRNA Signatures Distinguish Severe Alopecia Areata from Other Inflammatory Skin Diseases
- Clinico-Epidemiological Study of Scalp Dermatosis at Tertiary Care Centre in Central India
- Assessment of miR-19b-3p, miR-182-5p, and miR-155-5p expression and its relationship with alopecia areata severity
- Polarized microscopy in genetic hair disorders: case series
- Extensive Spiculated Follicular Porokeratosis With Alopecia: A Case Report
- Carotid Intima Media Thickness Measurement in Alopecia Areata Patients
- Folliculotropic mycosis fungoides of the scalp: A case report
- Nucleic acid-induced chemokine expression in keratinocytes: Implications for skin inflammation
- Trichoscopic Hallmarks in Non-cicatricial and Cicatricial Alopecia in Indian Population: A Narrative Review
- Vogt-Koyanagi-Harada Disease in which Poliosis and Alopecia Occurred after a Long Period of Time.
- Worldwide Clinical and Real-World Exposure to Baricitinib
- Generic vs. Disease-Specific Patient Reported Outcome (PRO) Instruments for Assessing HRQoL Burden Among Patients Diagnosed with Alopecia Areata: Evidence from TARGET-DERM AA
- CGF therapy: bridging androgenetic alopecia observations to psoriasis treatment via IL-17 pathway
- 52993 Regulatory γδ T cells protect human scalp hair follicles from alopecia areata in vivo
- Noval advance of histone modification in inflammatory skin diseases and related treatment methods
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Efficacy of Oral Apremilast in The Treatment of Alopecia Areata, at The Tertiary Care Hospital, Karachi
- Gene therapy for alopecia in type II rickets model rats using vitamin D receptor-expressing adenovirus vector
- Physiological Importance of the Vitaminoid Thiocyanate and Its Influence on Hair Growth
- 42752 Evaluation of Eyebrow and Eyelash Regrowth and Patient Satisfaction in the Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Psychosocial Aspects of Skin Conditions and Diseases
- A Severe Case of Folliculitis Decalvans